Probatech was founded to make sure that new opportunities in the life sciences are explored to their full potential.
We do this by bridging the early-stage innovation gap - by connecting pharma companies and investors with start-ups developing new drugs, vaccines or platform technologies.
For our pharma partners and investors, we source, curate and match them with the best opportunities for collaborations, licensing and acquisition globally.
With our Probacure service, we support early-stage start-ups with value propositions and partnering. If you're a start-up leader developing therapeutics, vaccines or platforms, please visit our Probacure website.
Together, we access hidden deal flow by combining technology with our sourcing expertise and networks at universities, accelerators and startup communities.
We then use our deep knowledge and expertise of healthcare and the pharma industry to save you time and triage opportunities, accelerating the search, evaluation and business development process.